2022—2023年柳州市B型流感病毒全基因组遗传特征分析

职业与健康 ›› 2024, Vol. 40 ›› Issue (21): 2900-2908.

2022—2023年柳州市B型流感病毒全基因组遗传特征分析

余钧池¹, 陈柳军¹, 刘一¹, 陈艺肖¹, 陈然琼¹, 居昱²

1.柳州市疾病预防控制中心微生物检验所,广西柳州 545007;
2.广西壮族自治区疾病预防控制中心急性传染病防制所,广西南宁 530000

收稿日期:2024-01-23 修回日期:2024-03-08 出版日期:2024-11-01 发布日期:2026-04-09
通信作者: 陈艺肖,主管检验技师,E-mail：1377528067@qq.com
作者简介:余钧池,女,主任技师,主要从事病原微生物检测工作。
基金资助:
广西重大传染病防控与生物安全应急响应重点实验室（广西壮族自治区疾病预防控制中心）开放基金（GKLKP-KF-202204）

Genetic characteristics analysis of the whole genome of influenza B virus in Liuzhou City from 2022 to 2023

YU Junchi¹, CHEN Liujun¹, LIU Yi¹, CHEN Yixiao¹, CHEN Ranqiong¹, JU Yu²

1. Microbiological Laboratory,Liuzhou Center for Disease Control and Prevention,Liuzhou,Guangxi 545007,China;
2. Acute Infectious Disease Prevention and Control Department,Guangxi Center for Disease Control and Prevention,Nanning,Guangxi 530000,China

Received:2024-01-23 Revised:2024-03-08 Online:2024-11-01 Published:2026-04-09
Contact: CHEN Yixiao,Laboratorian in charge,E-mail：1377528067@qq.com

摘要/Abstract

摘要： 目的分析2022—2023年柳州市B型流感病毒全基因组遗传特征,了解柳州市B型流感病毒变异情况及与WHO推荐疫苗株的匹配性。方法利用DNAStar、MEGA等生物信息学软件对分离的31株B型流感病毒的全基因序列进行比对构建基因进化树,分析同源性及氨基酸位点变异。结果 2022年柳州市B型流感病毒分离株属于C.1亚分支,只有神经氨酸酶（neuraminidase,NA）、膜蛋白（matrix protein,MP）和聚合酶A（polymerase A,PA） 3个基因片段与2020—2022年北半球疫苗推荐株B/Washington/02/2019在同一进化分支。2023年B型流感病毒分离株属于C.5.6或C.5.7亚分支,8个基因片段均与2022—2024年北半球疫苗推荐株B/Austria/1359417/2021在同一进化分支;相对于B/Austria/1359417/2021,2022—2023年柳州市B型流感病毒分离株血凝素（hemagglutinin,HA）基因在抗原决定簇和受体结合位点发生的氨基酸变异具有流行病学意义。柳州市31株B型流感病毒分离株HA蛋白和NA蛋白均未出现糖基化插入或缺失,未发生NA蛋白酶催化活性位点及耐药位点突变。部分流感病毒在非结构蛋白（non-structural protein,NS）和核蛋白（nucleoprotein,NP）的关键位点上发生了氨基酸变异,而组成RNA聚合酶的PA、聚合酶 B1（polymerase B1,PB1）及聚合酶 B2（polymerase B2,PB2）的3个蛋白存在2种主要共同变异方式。结论 2022年柳州市B型流感病毒与北半球疫苗推荐株B/Austria/1359417/2021的匹配性较差,2023年柳州市B型流感病毒与北半球疫苗推荐株B/Austria/1359417/2021的匹配性较好。流感病毒HA蛋白抗原决定簇和受体结合位点上氨基酸变异可能是引起B型流感病毒在柳州市流行的主要原因之一,流感病毒对使用的神经氨酸酶抑制剂的抗流感药物敏感。

关键词: B型流感病毒, 全基因组, 遗传特征, 疫苗推荐株

Abstract: Objective To analyze the genetic characteristics of the whole genome of the influenza B virus in Liuzhou City from 2022 to 2023,understand the variation of influenza B virus in Liuzhou City and its compatibility with the vaccine strains recommended by WHO. Methods Bioinformatics software such as DNAStar and MEGA were used to compare the complete gene sequences of 31 isolated influenza B virus,construct a gene evolutionary tree,and analyze homology and amino acid site variations. Results The influenza B virus isolated in Liuzhou City in 2022 belong to the C.1 sub-branch. Only the neuraminidase（NA）,matrix protein（MP） and polymerase A（PA） gene fragments share the same evolutionary branch as the northern hemisphere vaccine recommended strain B/Washington/02/2019 from 2020 to 2022. The influenza B virus in 2023 belonged to the C.5.6 or C.5.7 sub-branch,and all eight gene fragments were in the same evolutionary branch as the B/Austria/1359417/2021 recommended for the 2022 to 2024 vaccine. Relative to the vaccine recommended strain B/Austria/1359417/2021,the amino acid variation in the hemagglutinin（HA）gene of the influenza B virus isolated in Liuzhou City from 2022 to 2023 had epidemiological significance in the antigenic determinants and receptor binding sites. Respectively the Ha and Na proteins of 31 influenza B virus isolated from Liuzhou City did not show glycosylation insertion or deletion,and there were no mutations in the catalytic activity site and resistance site of Na protease. Some influenza viruses had amino acid mutations at key sites of the non-structural protein（NS） and nucleoprotein（NP）,and the PA,polymerase B1（PB1） and polymerase B2（PB2）,which composed RNA polymerase,had two main common variation patterns. Conclusion The influenza B virus isolates from Liuzhou City in 2022 was poorly matched to the northern hemisphere vaccine recommended strain B/Austria/1359417/2021,and the influenza B virus isolates from Liuzhou City in 2023 was well matched to the 2023 Northern Hemisphere vaccine recommended strain B/Austria/1359417/2021. The variation of amino acids in the antigenic determinants and receptor binding of HA protein of influenza B virus may be one of the main causes of influenza B virus epidemic in Liuzhou City. Influenza viruses are sensitive to the use of neuraminidase inhibitor anti-influenza drugs.

Key words: Influenza B virus, Whole genome, Genetic characteristics, Recommended vaccine strain

中图分类号:

R117

余钧池, 陈柳军, 刘一, 陈艺肖, 陈然琼, 居昱. 2022—2023年柳州市B型流感病毒全基因组遗传特征分析. [J]职业与健康, 2024, 40(21): 2900-2908.

YU Junchi, CHEN Liujun, LIU Yi, CHEN Yixiao, CHEN Ranqiong, JU Yu. Genetic characteristics analysis of the whole genome of influenza B virus in Liuzhou City from 2022 to 2023. [J]OCCUPATION AND HEALTH, 2024, 40(21): 2900-2908.

参考文献

[1] 李文娟,王大燕.我国流感疾病负担相关研究进展[J].中国人兽共患病学报,2019,35(10):928-933.
[2] 崔蕾,孙初阳,李丹丹,等.海南省2019—2020年H3N2亚型流感病毒血凝素基因特性[J].中国热带医学,2020,20(9):809-813.
[3] LI BL,TIAN T L,QING C W,et al.Genetic characterization and whole-genome sequencing-based genetic analysis of influenza virus in Jining City during 2021-2022[J].Front Microbiol,2023,14:1196451.
[4] 陈宏彬,张炎华,林琦,等.2016年福建省B型流感病毒基因特征分析[J].中国人兽共患病学报,2020,36(2):118-123.
[5] YU Y L.Pathogenicity and virulence of influenza[J].Virulence,2023, 14(1):115-126.
[6] ANDRES C,CUERPO M D,RABELLA N,et al.Detection of reassortant influenza B strains from 2004 to 2015 seasons in Barcelona(Catalonia,Spain) by whole genome sequencing[J].Virus Res,2023,6(330):199089.
[7] BIDZHIEVA B,ZAGORODNYAYA T,KARAGIANNIS K,et al.Deep sequencing approach for genetic stability evaluation of influenza A viruses[J].J Virol Methods,2014,199:68-75.
[8] VAN D H,VERHELT J,VUYLSTEKE M,et al.Analysia of the genetic diversity of influenza A viruses using next-generation DNA sequencing[J].BMC Genomics,2015,16(1):79.
[9] SUN S S,WANG Q Z,ZHAO F,et al.Prediction of biological functions on glycosylation site migrations in human influenza H1N1 viruses[J].PLoS One,2012,7(2):e32119.
[10] 孙海波,刘双,宋亦春,等.辽宁省2016—2017年H3N2亚型流感病毒HA1基因特征分析[J].中国微生态学杂志,2018,30(1):35-38.
[11] 曾晓旭,王大燕,舒跃龙.B型流行性感冒病毒基因进化研究进展[J].中华预防医学杂志,2013,47(7):656-658.
[12] 黄世腾,杨瑞军,吕磊,等.2015—2017年浙江省衢州市H3N2亚型流感病毒血凝素基因分子进化特征分析[J].疾病监测,2018,33(6):483-487.
[13] 孔政. 2017—2019年济宁市甲型H1N1流感病毒基因特征分析[J].预防医学论坛,2021,27(11):838-841.
[14] FANG Z C,TENG L,JIA G X,et al.Key amino acid residues of neuraminidase involved in influenza a virus entry[J].Pathogens and Disease,2019,77(6):1-9.
[15] 刘丽,孙爱猛,罗青,等.2016—2017年吉安市乙型流感病毒基因特征分析[J].实验与检验医学,2018,36(6):833-835.
[16] 王莹丽,蒋艳,朱瑞芳,等.全球与中国流感病毒对NAIs耐药性趋势及特征[J].中华医院感染学杂志,2020,30(2):272-277.
[17] 朱冰,钟家禹,周荣,等.2010年与2011年流感病毒广州分离株全基因组序列分析[J].中华医院感染学杂志,2013,23(9):2012-2014.
[18] NG A K,LAM M K,ZHANG H,et al.Structural basis for RNA binding and homo-oligomer formation by influenza B virus nucleoprotein[J]. J Virol,2019,86(12):6758-6767.
[19] CAO S,JIANG J,LI J,et al.Characterization of the nucleocytoplasmic shuttle of the matrix protein of influenza B virus[J].J Virol,2014,88(13):7464-7473.
[20] JUMAT M R,WONG P,LEE R T,et al.Molecular and biochemical characterization of the NS1 protein of non-cultured influenza B virus strains circulating in Singapore[J].Microbial Genomics,2016,2(8):e000082.